Institutional Ownership
Lexeo Therapeutics Inc
CUSIP 52886X107COMLXEOQ1 2026
Institutional Holders
133
13F filers
Shares Held
75.77M
Aggregate institutional
Institutional Value
$434.54M
Q1 2026
Net New Holders
-8
17 new · 25 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions17
Increased58
Decreased37
Sold out25
Institutional Holders
133 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Paradigm Biocapital Advisors LP | 6.18M | $35.50M | +1.42M | Added |
| 2 | Blackrock, Inc. | 5.11M | $29.34M | +203.3K | Added |
| 3 | Affinity Asset Advisors, LLC | 5.05M | $28.99M | +1.85M | Added |
| 4 | Ra Capital Management, L.P. | 5.00M | $28.70M | 0 | Held |
| 5 | Janus Henderson Group PLC | 4.98M | $28.51M | −533.2K | Reduced |
| 6 | Vestal Point Capital, LP | 4.47M | $25.69M | 0 | Held |
| 7 | Frazier Life Sciences Management, L.P. | 4.42M | $25.40M | 0 | Held |
| 8 | Citadel Advisors LLC | 3.83M | $22.01M | +60.7K | Added |
| 9 | Orbimed Advisors LLC | 3.60M | $20.68M | +1.48M | Added |
| 10 | State Street Corp | 3.57M | $20.48M | +380.5K | Added |
123 more institutional holders on Premium
See every fund holding Lexeo Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders